Phibro Animal Health has filed to raise up to $230 million in an IPO, planning to list on the NASDAQ under the symbol PAHC. A global animal health and mineral nutrition company, Phibro sells more than 1,100 products for food animals including poultry, swine, beef and dairy cattle, and aquaculture.
In 2000, Phibro (then Philipp Brothers Chemicals) sold a minority stake to Palladium Equity Partners for $45 million in order to finance the acquisition of Pfizer's medicated-feed products. The company later redeemed the shares for $26.4 million. Selling stockholder 3i Group acquired a minority stake in 2008 for a total consideration of $97.2 million.